Nectid views its intellectual properties are critical in protecting its investments and in finding a marketing partner to license these drugs. Its pipeline is protected by a number of patent applications.
Currently its products and technologies are protected by over 50 patent applications in novel uses, dosage forms and new chemical entities design areas. Some of these patent applications have been already partnered under option agreements with its development partners.
Nectidís patents have been demonstrated to be valuable through acquisitions by a number of branded pharmaceutical companies in the last three years.